
Telomir Pharmaceuticals Inc (NASDAQ:TELO) experienced an increase of 138.84% in its stock value during after-hours trading on Thursday, noting a regular trading session surge of 5.22% to reach $1.21.
What Happened: The surge in stock value followed the announcement of promising data regarding the company’s lead candidate, Telomir-1. The data indicated that Telomir-1 could reverse epigenetic gene silencing, restoring the tumor suppressor in human prostate cancer cells. This performance surpassed that of chemotherapy and rapamycin.